ArticleFrontiers in oncology2026
Integrative analysis reveals PRKCB and SRD5A2 as potential immune-associated biomarkers in prostate cancer targeted by traditional Chinese medicine.
Qi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.